Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study
Clinical trial NCT05430854 · TERMINATED
Trial details
- NCT number
- NCT05430854
- Sponsor
- Amgen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-01
- Primary completion
- 2023-10-31
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.